Latest news
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store - BioSpaceBioSpace · Thu, 30 Jul 2026 07:00:00 GMTBiogen flips '26 guidance from expected decline to sales increase - fiercepharma.comfiercepharma.com · Wed, 29 Jul 2026 15:05:32 GMT‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while - fiercebiotech.comfiercebiotech.com · Wed, 29 Jul 2026 14:48:11 GMTBiogen beats estimates as new medicines overtake multiple sclerosis business - The Edge MalaysiaThe Edge Malaysia · Wed, 29 Jul 2026 07:00:00 GMT